Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flammini

Showing results (221-230 of 227) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 227 results.
Journal of Experimental & Clinical Cancer Research : CR|May 30, 2019
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLCSilvia La Monica, Roberta Minari, Daniele Cretella, et al.
Cells|July 2, 2021
Inhibition of Human Malignant Pleural Mesothelioma Growth by Mesenchymal Stromal CellsValentina Coccè, Silvia La Monica, Mara Bonelli, et al.
Scientific Reports|March 19, 2024
Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell modelsSilvia La Monica, Federica Vacondio, Kamal Eltayeb, et al.
Small (Weinheim an Der Bergstrasse, Germany)|November 5, 2024
Phage-Templated Synthesis of Targeted Photoactive 1D-Thiophene NanoparticlesPaolo Emidio Costantini, Roberto Saporetti, Marika Iencharelli, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|November 4, 2005
[The Dialysis Outcomes and Practice Patterns Study (DOPPS): results of the Italian cohort]G Pontoriero, D Santoro, A Messina, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|February 19, 2008
[Patient satisfaction in hemodialysis: a pilot cross-sectional analysis and a review]F Pansini, L Gargano, M Sambati, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|July 9, 2013
[Effects of dose of erythropoiesis stimulating agents on cardiovascular outcomes, quality of life and costs of haemodialysis. the clinical evaluation of the DOSe of erythropoietins (C.E. DOSE) Trial]V Saglimbene, D D'Alonzo, M Ruospo, et al.
Pageof 23

Showing results (221-230 of 227) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 227 results.
Journal of Experimental & Clinical Cancer Research : CR|May 30, 2019
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLCSilvia La Monica, Roberta Minari, Daniele Cretella, et al.
Cells|July 2, 2021
Inhibition of Human Malignant Pleural Mesothelioma Growth by Mesenchymal Stromal CellsValentina Coccè, Silvia La Monica, Mara Bonelli, et al.
Scientific Reports|March 19, 2024
Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell modelsSilvia La Monica, Federica Vacondio, Kamal Eltayeb, et al.
Small (Weinheim an Der Bergstrasse, Germany)|November 5, 2024
Phage-Templated Synthesis of Targeted Photoactive 1D-Thiophene NanoparticlesPaolo Emidio Costantini, Roberto Saporetti, Marika Iencharelli, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|November 4, 2005
[The Dialysis Outcomes and Practice Patterns Study (DOPPS): results of the Italian cohort]G Pontoriero, D Santoro, A Messina, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|February 19, 2008
[Patient satisfaction in hemodialysis: a pilot cross-sectional analysis and a review]F Pansini, L Gargano, M Sambati, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|July 9, 2013
[Effects of dose of erythropoiesis stimulating agents on cardiovascular outcomes, quality of life and costs of haemodialysis. the clinical evaluation of the DOSe of erythropoietins (C.E. DOSE) Trial]V Saglimbene, D D'Alonzo, M Ruospo, et al.
Pageof 23